MIC
GILD icon

Means Investment Company’s Gilead Sciences GILD Stock Holding History

Means Investment Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$677K Buy
4,858
+5
+0.1% +$700 0.06% 110
2025
Q4 		$596K Sell
4,853
-1,034
-18% -$126K 0.05% 114
2025
Q3 		$653K Sell
5,887
-148
-2% -$16.8K 0.06% 110
2025
Q2 		$669K Buy
6,035
+344
+6% +$36.6K 0.06% 107
2025
Q1 		$638K Sell
5,691
-547
-9% -$56.4K 0.07% 110
2024
Q4 		$576K Buy
6,238
+12
+0.2% +$1.08K 0.06% 118
2024
Q3 		$522K Buy
6,226
+5
+0.1% +$382 0.06% 121
2024
Q2 		$427K Sell
6,221
-72
-1% -$4.8K 0.05% 129
2024
Q1 		$461K Sell
6,293
-394
-6% -$30.3K 0.06% 131
2023
Q4 		$542K Sell
6,687
-109
-2% -$8.48K 0.08% 122
2023
Q3 		$509K Sell
6,796
-55
-0.8% -$4.23K 0.08% 121
2023
Q2 		$528K Sell
6,851
-126
-2% -$10K 0.08% 119
2023
Q1 		$579K Sell
6,977
-59
-0.8% -$4.89K 0.1% 109
2022
Q4 		$604K Sell
7,036
-183
-3% -$14.5K 0.12% 105
2022
Q3 		$445K Buy
7,219
+621
+9% +$39.2K 0.1% 120
2022
Q2 		$408K Buy
6,598
+77
+1% +$4.77K 0.09% 127
2022
Q1 		$388K Buy
6,521
+16
+0.2% +$1.02K 0.07% 133
2021
Q4 		$472K Sell
6,505
-18
-0.3% -$1.24K 0.08% 118
2021
Q3 		$456K Sell
6,523
-288
-4% -$20.2K 0.09% 115
2021
Q2 		$469K Sell
6,811
-96
-1% -$6.41K 0.09% 117
2021
Q1 		$446K Sell
6,907
-79
-1% -$5.09K 0.1% 115
2020
Q4 		$467K Sell
6,986
-954
-12% -$57.6K 0.11% 111
2020
Q3 		$469K Sell
7,940
-620
-7% -$43K 0.13% 95
2020
Q2 		$583K Sell
8,560
-23
-0.3% -$1.76K 0.18% 76
2020
Q1 		$698K Buy
8,583
+742
+9% +$51.3K 0.27% 68
2019
Q4 		$494K Sell
7,841
-468
-6% -$30.5K 0.17% 80
2019
Q3 		$542K Sell
8,309
-1,215
-13% -$79.4K 0.2% 81
2019
Q2 		$645K Sell
9,524
-260
-3% -$17.1K 0.26% 74
2019
Q1 		$636K Sell
9,784
-779
-7% -$51.8K 0.28% 73
2018
Q4 		$661K Buy
+10,563
New +$738K 0.37% 67

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Means Investment Company's GILD Position: Q1 2026 in Review

Means Investment Company increased its Gilead Sciences (GILD) stake by 0.1% in Q1 2026, buying an estimated $700 and bringing the position to 4,858 shares worth $677K. The position accounts for 0.06% of the portfolio, ranked #110.

Means Investment Company first reported a position in GILD in Q4 2018 and has held it in 30 quarters since. The position peaked at $698K in Q1 2020. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Means Investment Company held 4,858 shares of Gilead Sciences worth $677K as of Q1 2026.
  • Means Investment Company bought 5 Gilead Sciences shares in Q1 2026, an estimated $700.
  • Gilead Sciences made up 0.06% of Means Investment Company's portfolio in Q1 2026, its #110 holding.
  • Means Investment Company first reported a position in Gilead Sciences in Q4 2018 and has held it in 30 quarters since.
  • Means Investment Company's Gilead Sciences position peaked at $698K in Q1 2020.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Means Investment Company's 13F filing for Q1 2026, filed 24 Apr 2026.